Comments

Exact Sciences Stock Price, Quotes and Forecasts

Q: What sector and industry does Exact Sciences (EXAS) operate in?

Exact Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

EXASNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$56.42

At close: May 16, 6:22 PM EDT

$56.21

-0.21-0.37%

Pre-Market: May 16, 6:22 PM EDT

Exact Sciences (EXAS) Forecast

News Earnings Exact Sciences (EXAS) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Exact Sciences Stock Price, Quotes and Forecasts | NASDAQ:EXAS | Benzinga

Explore Exact Sciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for EXAS.

Open	-
Close	-
Volume / Avg.	103.00 / 2.69M
Day Range	- - -
52 Wk Range	39.97 - 72.83
Market Cap	$10.60B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	72
Short Interest	6.13%
Days to Cover	4.73

Recent News

Duolingo, CoreWeave And DexCom Are Among Top 10 Large-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?

Top performing large-cap stocks in the last week: DUOL, CRWV, THC, CARR, SMMT, AUR, ANET, TT, DXCM, XPO. Most had positive financial results and raised guidance.

Lekha Gupta

Trupanion Posts Better-Than-Expected Results, Joins Duolingo, DexCom, Exact Sciences And Other Big Stocks Moving Higher On Friday

Avi Kapoor

Cancer Diagnostic Firm Exact Sciences' CEO Says Strong Q1 Paves Way For 'Transformative' 2025, Lifts Annual Guidance

Exact Sciences posted better-than-expected Q1 results and lifted its 2025 outlook, signaling confidence in growth and operational momentum.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	103.00 / 2.69M
Day Range	- - -
52 Wk Range	39.97 - 72.83
Market Cap	$10.60B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	72
Short Interest	6.13%
Days to Cover	4.73

About Exact Sciences Corp.

Sector

Health Care

Industry

Biotechnology

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test p...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Exact Sciences (EXAS) stock?

You can purchase shares of Exact Sciences (NASDAQ:EXAS) through any online brokerage.

View our list of the best stock brokerages

Who are Exact Sciences (EXAS) competitors?

Other companies in Exact Sciences’s space includes: BeiGene (NASDAQ:ONC), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV), Amgen (NASDAQ:AMGN) and United Therapeutics (NASDAQ:UTHR).

What is the forecast, or price target, for Exact Sciences (EXAS) stock?

Exact Sciences has a consensus price target of $72.28.

What is the current price for Exact Sciences (EXAS)?

The stock price for Exact Sciences (NASDAQ: EXAS) is $56.21 last updated May 16, 2025 at 6:22 PM EDT.

Does Exact Sciences (EXAS) pay a dividend?

There are no upcoming dividends for Exact Sciences.

When is Exact Sciences (NASDAQ:EXAS) reporting earnings?

Exact Sciences’s Q2 earnings are confirmed for Wednesday, July 30, 2025.

Is Exact Sciences (EXAS) going to split?

There is no upcoming split for Exact Sciences.

What sector and industry does Exact Sciences (EXAS) operate in?

Exact Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.